A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)

Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
11/2001
11/07/2001	EP1152007A1 Ether type lipid a1-carboxylic acid analogues
11/07/2001	EP1151995A1 Process for the preparation of the mesylate salt trihydrate of 1-(4-Hydroxyphenyl)-2-(4-Hydroxy-4-Phenylpiperidin-1-YL)-1-Propanol
11/07/2001	EP1151754A1 Use of a equine milk fraction for the inhibition of interleukin-1 production
11/07/2001	EP1151113A2 Human peptidases
11/07/2001	EP1151101A1 Prostacyclin-stimulating factor-2
11/07/2001	EP1151100A1 Tau-conotoxin peptides
11/07/2001	EP1151095A1 Polypeptide variants with raised heparin-binding capacity
11/07/2001	EP1151067A1 Process of converting rendered triglyceride oil from marine sources into bland, stable oil
11/07/2001	EP1151012A1 Rhamm antagonist antibodies
11/07/2001	EP1151011A1 Anti-ccr1 antibodies and methods of use therefor
11/07/2001	EP1151000A2 Polymeric immunoglobulin receptor (pigr)-binding domains and methods of use therefor
11/07/2001	EP1150997A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
11/07/2001	EP1150991A2 Compositions for treating inflammatory response
11/07/2001	EP1150982A1 PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND I$g(k)-A$g(a)
11/07/2001	EP1150976A1 3-(thio-substituted amido)-lactams useful as inhibitors of matrix metalloproteinase
11/07/2001	EP1150970A1 (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same
11/07/2001	EP1150965A1 Benzazepine derivatives as alpha-v integrin receptor antagonists
11/07/2001	EP1150960A1 Polymorphic crystalline forms of celecoxib
11/07/2001	EP1150959A1 Solid-state form of celecoxib having enhanced bioavailability
11/07/2001	EP1150955A2 G-protein coupled heptahelical receptor binding compounds and methods of use thereof
11/07/2001	EP1150954A1 Anti-imflammatory indole derivatives
11/07/2001	EP1150953A1 Indole derivatives and their use as mcp-1 receptor antagonists
11/07/2001	EP1150952A1 Indole derivatives and their use as mcp-1 receptor antagonists
11/07/2001	EP1150950A2 Anthranilic acid derivatives
11/07/2001	EP1150704A1 New use of melagatran
11/07/2001	EP1150691A2 Novel antisense inhibition of rad51
11/07/2001	EP1150690A1 Chemical compounds
11/07/2001	EP1150689A1 Chemical compounds
11/07/2001	EP1150666A1 Stimulating neutrophil function to treat inflammatory bowel disease
11/07/2001	EP1150661A2 Topical sprays comprising a film forming composition
11/07/2001	EP1150660A1 Pharmaceutical effervescent formulation containing metamizol
11/07/2001	EP1150658A2 Method for controlling liposome size
11/07/2001	EP1150570A1 Activation of regulatory t cells by alpha-melanocyte stimulating hormone
11/07/2001	EP1150564A1 Inositol derivatives for inhibiting superoxide anion production
11/07/2001	EP0879223B1 Aromatic polycyclic retinoid-type derivatives, method for preparing same, and use thereof for making pharmaceutical and cosmetic compositions
11/07/2001	EP0861235B1 Substituted benzylaminopiperidine compounds
11/07/2001	EP0802917B1 Aryl substituted 5,5 fused aromatic nitrogen compounds as anti-inflammatory agents
11/07/2001	EP0758452B1 Modulators of cytokines of the tgf-beta superfamily and methods for assaying for same
11/07/2001	EP0655996B1 Substituted benzylamino nitrogen containing non-aromatic heterocycles
11/07/2001	EP0626939B1 Tri-substituted phenyl derivatives as phosphodiesterase inhibitors
11/07/2001	CN1321157A Substd. imidazo [1,2] azines as selective inhibitors of COX-2
11/07/2001	CN1321151A Chemical compounds
11/07/2001	CN1321150A Amide derivs. useful as inhibitors of production of cytokines
11/07/2001	CN1321087A MGluR 5 antagonists for treatment of pain and anxiety
11/07/2001	CN1321086A Mucosal originated drug delivery system and animal applications
11/07/2001	CN1321083A Method for making coated gabapentine or pregabaline particles
11/07/2001	CN1321080A Fast dissolving orally consumable films
11/07/2001	CN1320442A Medicine for treating rheumatisms
11/07/2001	CN1320438A Process for preparing medicines
11/07/2001	CN1320429A Medical liquor for treating injury
11/07/2001	CN1074294C Method for producing medicinal liquor for treating rheumatism
11/06/2001	USRE37438 Acetamidine derivatives and their use as inhibitors for the nitric oxide synthase
11/06/2001	US6313302 Opioid kappa receptor antagonists; side effect reduction; analgesics, antiinflammatory agents, anesthetics, and neuroprotectants
11/06/2001	US6313269 Tumor necrosis factor related receptor, TR6
11/06/2001	US6313174 Aminobenzophenones as inhibitors of interleukin and TNF
11/06/2001	US6313172 Administering hydroxyethylthiourea derivative for therapy of pain in mammal
11/06/2001	US6313162 Propynyl or dienyl biaromatic compounds
11/06/2001	US6313156 Thiazole compounds as cyclic-AMP-specific phosphodiesterase inhibitors
11/06/2001	US6313148 For therapy of pain pain associated with joint conditions such as rheumatoid arthritis and osteoarthritis, postoperative pain, post-partum pain, the pain associated with dental conditions such as dental caries and gingivitis
11/06/2001	US6313129 Therapeutic compounds
11/06/2001	US6313120 Treatment or prevention of diseases involving bradykinin receptors
11/06/2001	US6313116 Phosphodiesterase inhibitors
11/06/2001	US6313107 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI
11/06/2001	US6312753 Cocoa components, edible products having enriched polyphenol content, methods of making same and medical uses
11/06/2001	US6312693 Antibodies against human CD40
11/06/2001	US6312689 Antibodies or antigens
11/01/2001	WO2001081928A1 Diagnostic assay and method of treatment involving macrophage inhibitory cytokine -1 (mic-1)
11/01/2001	WO2001081622A2 Diagnosis of diseases associated with dna repair
11/01/2001	WO2001081590A2 Protein phosphatases
11/01/2001	WO2001081585A2 A thymus expressed human cytochrome p450 (p450tec)
11/01/2001	WO2001081581A2 Compositions and methods for the therapy and diagnosis of acne vulgaris
11/01/2001	WO2001081574A2 Regulation of nf-at interacting protein nip 45 variant
11/01/2001	WO2001081551A2 Retinal pigment epithelial cell lines with extended life-span and their applications
11/01/2001	WO2001081415A2 Parathyroid hormone and parathyroid hormone-related protein antagonists
11/01/2001	WO2001081377A2 Integrin/adhesion antagonists
11/01/2001	WO2001081369A2 Peptide potentiation of acid-sensory ion channel in pain
11/01/2001	WO2001081363A1 Novel compounds
11/01/2001	WO2001081348A1 USE OF 5-THIO-, SULFINYL- AND SULFONYLPYRAZOLO[3,4-b]-PYRIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS
11/01/2001	WO2001081346A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta
11/01/2001	WO2001081342A2 Novel epothilone derivatives, method for the preparation thereof and their pharmaceutical use
11/01/2001	WO2001081340A2 Heterocycles that are inhibitors of impdh enzyme
11/01/2001	WO2001081337A1 Inhibitors of dipeptidyl peptidase iv
11/01/2001	WO2001081333A2 Regioselective synthesis of 3,4-di(carbocyclyl or heterocyclyl)thiophenes
11/01/2001	WO2001081332A2 2-fluorobenzenesulfonyl compounds for the treatment of inflammation
11/01/2001	WO2001081323A1 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments
11/01/2001	WO2001081316A2 Substituted phenyl farnesyltransferase inhibitors
11/01/2001	WO2001081314A1 Naphthamidine urokinase inhibitors
11/01/2001	WO2001081312A2 Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore
11/01/2001	WO2001081311A1 Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis
11/01/2001	WO2001081310A1 1-aroyl-piperidinyl benzamidines
11/01/2001	WO2001081309A2 4-benzyl-1-[2-(4-hydroxy-phenoxy)-ethyl]-piperidine-3,4-diol
11/01/2001	WO2001081304A1 Inhibitors of dipeptidyl peptidase iv
11/01/2001	WO2001081298A2 Cyclic carboxylic acids as integrin antagonists
11/01/2001	WO2001081295A1 Cyclohexylamine derivative as subtype selective nmda receptor antagonists
11/01/2001	WO2001080937A1 Drug delivery device for insertion in the vagina, rectum or nasal cavity
11/01/2001	WO2001080865A2 Joint repair using mesenchymal stem cells
11/01/2001	WO2001080864A2 Chemical modification of mammalian urine and blood
11/01/2001	WO2001080825A2 Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
11/01/2001	WO2001080823A2 Composition exhibiting enhanced formulation stability and delivery of tropical active ingredients
11/01/2001	WO2001060381B1 Nucleoside analogs with carboxamidine-modified bicyclic base

1 ... 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 ... 1272